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Abstract
Background: Allergic diseases are more common in Finland than in Estonia, which—according to the 
biodiversity hypothesis—could relate to differences in early microbial exposures. 
Methods: We aimed at defining possible microbial perturbations preceding early atopic sensitisation. 
Stool, nasal, and skin samples of 6-month-old DIABIMMUNE study participants with HLA susceptibility to 
type 1 diabetes were collected. We compared microbiotas of sensitised (determined by specific IgE-
results at 18 months of age) and unsensitised Estonian and Finnish children.
Results: Sensitisation was differentially targeted between populations, as egg- and birch pollen-specific 
IgE was more common in Finland. Microbial diversity and community composition also differed; the genus 
Acinetobacter was more abundant in Estonian skin- and nasal samples. Particularly, the strain level profile 
of Acinetobacter lwoffii was more diverse in Estonian samples. Early microbiota was not generally 
associated with later sensitisation. Microbial composition tended to differ between children with or 
without IgE-related sensitisation, but only in Finland. While land-use pattern (i.e. green areas vs. urban 
landscapes around the children’s homes) was not associated with microbiota as a whole, it associated 
with the composition of the genus Acinetobacter. Breastfeeding affected gut microbial composition and 
seemed to protect from sensitisation.
Conclusions: In accordance with the biodiversity hypothesis, our results support disparate early exposure 
to environmental microbes between Finnish and Estonian children and suggest a significant role of the 
genus Acinetobacter in the allergy gap between the two populations. The significance of the observed 
differences for later allergic sensitisation remains open.
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1. Introduction
Immune-mediated diseases such as allergies and autoimmune diseases represent one possible cost of our 
urbanised lifestyle. Reduced contact with diverse microbiotas of natural environments contributes to the 
rising epidemic of immune-mediated diseases, as explained by the biodiversity hypothesis of allergic 
disease.1 Many factors, such as living on a farm, having older siblings, having pets, etc., have been linked 
to decreased risk for allergy and atopy.2-4 All of these factors, which either vanish or become less likely 
with an urban lifestyle, could be traced back to increased exposure to environmental microbes,5 which 
potentially translates into increased microbial colonisation to the body. Importantly, some of these 
environmental microbes have been linked to increasing immune tolerance.5-7 
A living laboratory to test the biodiversity hypothesis exists across the Finnish borders. 
Westernized living conditions in Finland meet a more traditional lifestyle on the Russian side. Studying 
these contrasting populations, a three- to ten-fold increased prevalence of asthma or allergic 
sensitisation,4,8 a four-fold increased prevalence of coeliac disease,9 and a six-fold increased incidence of 
type 1 diabetes has been reported in Finland,10 as compared to Russian Karelia. Estonia is a country of 
intermediate level of westernization compared to Finland and Russia. It has also witnessed a rapid 
socioeconomic growth since its independence in 1991. Type 1 diabetes and celiac disease are three times 
more common in Finland compared to Estonia,11,12 and wheezing during the past year has been reported 
in 7-10% of Estonian compared to 15-20% of Finnish children.13,14 Similarly, atopic dermatitis and skin 
prick test positivity are more prevalent among Swedish infants (24%) as compared to Estonian infants 
(~14%).15 According to the DIABIMMUNE study, allergic sensitisation to any allergen by the age of 3 years 
was more common in Finland compared to Estonia (45.6 vs. 32.4%, P = .001; Mustonen N, personal 
communication).
These reported differences in epidemiology have been shown to parallel differences in the 
human microbiotas,8,16 which is likely to reflect differential exposure to environmental microbes. Gut 
microbial composition has been shown to differ significantly between Finnish and Russian children, but 
not substantially so between Finnish and Estonian children.16 Also, skin and nasal microbiotas were 
contrastingly different in composition between adolescents from Russian and Finnish Karelia.8 This is in 
line with many other observations that dysbiosis – abnormal/imbalanced microbiota – is associated with 
the development of inflammatory disorders.17 
Many previous studies have compared either school children or young adults. However, 
environmental exposures crucial to later development of allergic diseases may occur during early life.3,18 
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and Estonia. Our aim was to search for early differences in the commensal microbiota that might predict 
early allergic sensitisation and the gap in the prevalence of allergic diseases between these two 
populations.
2. Materials and Methods
2.1 Subjects and sample collection
The DIABIMMUNE birth cohort (BC) was a prospective study in Finland, Estonia and Russia following 
children with HLA susceptibility to type 1 diabetes from birth until the age of 3 years from September 
2008 to October 2013.12 Blood and swab samples were collected at the study center visits (3, 6, 12, 18, 24, 
and 36 months of age). 
For this study, children observed to be sensitised according to the IgE results by the age of 
18 months were included from the Finnish (n=387) and Estonian DIABIMMUNE cohorts (n=330). 
Unfortunately, not enough Russian samples were available for this study. The allergen-specific IgE levels 
tested at 18 months of age were cat, hen’s egg, cow’s milk, peanut, birch, timothy, and dust mite 
(Dermatophagoides pteronyssinus). To include only children with a definite allergic sensitisation, a cut-off 
of IgE≥0.7 kU/L in at least one serum allergen-specific IgE level was used for the identification of cases 
instead of the standard cut-off of 0.35 kU/L. In the statistical analyses, we classified subjects as sensitized, 
based on an empirical cut-off of the maximum specific IgE value, set at –0.5 on log10 scale (Fig. S1 in 
supplementary material). Table S1 shows the proportion of Finnish and Estonian study participants with 
positive sIgE responses (≥0.35 kU/L) to the seven allergens tested at the age of 18 months.
The inclusion criteria resulted in the identification of 70 Finnish children (18.1%) but only 
28 Estonian children (8.5%) with allergic sensitisation, reflecting the existing gap in allergy prevalence 
between these two populations. For the 70 Finnish children, we included 70 country-matched controls 
with no allergen-specific IgE levels above 0.35 kU/L at the age of 18 months. Due to the lower number of 
sensitised children in Estonia, we included two controls for the 28 Estonian children. In total, this study 
comprised 224 children (117 boys), 98 children with definite allergic sensitisation by allergen-specific IgE 
levels at 18 months of age, and 126 controls. Table S2 presents the demographic and other characteristics 
of the Finnish and Estonian study participants and Table S3 the corresponding characteristics in the 
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Stool, skin and nasal samples were collected at the age of 6 months. Nasal swab samples 
were available for 217 children (nFin = 135, nEst = 82), skin swab samples for 172 children (nFin = 111, nEst = 
61), and stool samples for 218 children (nFin = 135, nEst = 83). A complete set of samples was obtained from 
162 children (nFin = 102, nEst = 60). For those children without a stool sample at 6 months of age, a sample 
at 5 months was selected (n=14), and for those lacking both samples, a sample at 7 months was selected 
(n=2).
The local ethics committees approved the DIABIMMUNE study protocol, and legal 
guardians of the study participants gave their written informed consent.
2.2 Land-use patterns
Land use was calculated with the CORINE2012 land-cover data, using five land-use types: agricultural land, 
built area, forest, water bodies and wetland. We used a buffer with a radius of 3 km around the homes.19
2.3 DNA extraction and sequencing
Bacterial composition was determined after DNA extraction by amplifying V1-V3 regions of bacterial 
16S rRNA genes by polymerase chain reaction (PCR) (see online supplement).
2.4 Bioinformatics
The bioinformatics methods have been described in the online supplement. 
2.5 Statistics 
We tested the ability of microbial composition to classify individuals according to national identity, using 
random forest analysis, as implemented in the randomForest package20. This analysis was also used to 
identify characteristic operational taxonomic units (OTUs) of each group. Prior to analysis, in order to limit 
the number of feature included in the analysis, we selected only those OTUs having a variance higher than 
the median variance across all OTUs. An optimal number of trees was selected based on classification 
error and an optimal number of randomly selected variables used in the analysis was sought using the 
train function in the caret package21, based on 10-fold cross validation. Due to imbalanced sample sizes – 
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predicted reliably, we took a random sample of nskin=60, nnasal=80, and nstool=80 samples from each 
population to be used in the analysis. The number of features used were 1,391 for skin and nasal 
microbiota, and 1,387 for stool microbiota. For skin, nasal, and stool samples we used 100, 100, and 200 
trees, respectively, and 100, 197, and 100 random features, respectively.
Questionnaire data on animal contact was converted to binary form (by coding 
high/prominent contact with 1 and low/infrequent contact with 0). The resulting data was used to 
calculate an aggregate estimate of the intensity of animal contact, with principal component analysis 
(PCA), where the first PCA axis was used in the analysis.
A more detailed description of the methods can be read in the online supplement.
3. Results
3.1 Between-population differences in allergic sensitisation
For the statistical analyses, we used the maximum specific IgE values, measured at the age of 18 months, 
to classify individuals to either ‘healthy’ or ‘sensitised’, setting the cut-off at –0.5 on log10 scale (0.61 on 
arithmetic scale; based on the frequency distribution of IgE values, Fig. S1). The maximum IgE at 18 
months correlated relatively well with that at 6 months (n6=210; Spearman   = 0.69, P < .0001) and 36 
months (n36=198; Spearman  = 0.74, P < .0001). These correlations did not differ markedly between 
population cohorts. 
The IgE values of individual allergens were generally very low; the medians of all measured 
allergens were less than 0.1 kU/L. As low measures below 0.1 kU/L are not considered to be trustworthy, 
we used this level as cut-off. The data suggests egg- and birch-specific IgE is elevated in Finland (egg: 
ORFinland = 2.22, CI = [1.25, 3.95], P = 0.0068; birch: ORFinland = 4.69, CI = [1.04, 21.17], P = 0.045). 
Interestingly, house dust mite-specific IgE was elevated in Estonia, but the difference was not statistically 
significant (ORFinland = 0.36, CI = [0.11, 1.14], P = 0.083). These results suggests that the immune response 
might be differently targeted between the populations, even at this early age, which is in accordance with 
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3.2 Patterns in the composition of microbiota
The sequencing resulted in 2,782 OTUs shared between both sequencing runs in the 607 samples from 
skin, nasal and stool, obtained at the age of 6 months. Microbial diversity was highest in the skin samples 
(P = .0004) and lowest in the stool samples (P < .0001) (Fig. 1). Across all samples, Estonian children 
tended to have higher microbial diversity, as compared to Finnish children (P < .0001), and especially so 
when considering either skin or stool samples. Considering diversity between the populations, as well as 
healthy and sensitised children (assessed at 18 months), the only significant difference was that the 
Estonian children had more diverse microbiota in their stool compared to Finnish children (P = .007). In 
the skin samples from Estonia, diversity tended to be higher in sensitised children as compared to healthy 
children (P = .028) (Fig. 1).
Microbial community composition differed most clearly between populations when 
considering skin samples [multiple regression on distance matrices (MRM) on weighted UniFrac: R2 = .08, 
P < .001; Fig. 2a)], followed by the nasal samples (R2 = .03, P < .001; Fig. 2b), and stool samples (R2 = .02, 
P < .001; Fig. 2c). Significant differences between healthy and sensitised children were observed both in 
the nasal and stool samples, but only among Finnish children (MRM on Bray&Curtis: nasal: R2 = .02, 
P < .001; stool: R2 = .01, P = .013). These analyses were corroborated by random forest classification (RFC). 
The overall classification accuracy (based on 10-fold cross validation of a random subsample of the data) 
was highest for skin microbiota (accuracy = 92.5%), followed by nasal (accuracy = 91.9%), and stool 
microbiota (accuracy = 81.3%). In all cases, subject recall was higher for Finnish than for Estonian subjects: 
nasal samples Fin = 92.5%, Est = 91.3%; skin samples Fin = 95%, Est = 90%; stool samples Fin = 86.3%, 
Est = 76.3%. 
Using RFC, we were able to assess the most important OTUs differentiating between 
Finnish and Estonian children (Fig 2.). In both nasal and skin samples the most important OTU belonged to 
genus Acinetobacter (OTU-108) (Fig. 2a,b). This OTU was more abundant in Estonian children as compared 
to Finnish children – on average over 20 times more abundant on the skin (Pskin < .0001) and four times 
more abundant on the nasal epithelium (Pnasal = .0025) (Fig. 3a). Furthermore, it could be identified to 
species A. lwoffii (a blast search against the NCBI 16S ribosomal RNA sequence database gave a 99% 
match over 486 nucleotides). The “strain” level profile was also found to be different between Finnish and 
Estonian children using an oligotyping pipeline (R2 = .06, P < .001, based on Bray&Curtis dissimilarity, 
correcting for sample type; Fig 3b). Again, the strain profile of OTU-108 was more diverse (measured by 
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especially between healthy and sensitised Finnish children, these differences were not statistically 
significant.
3.3 Living environment affecting skin & nasal microbiota
Land-use patterns, characterised as the first principal component of land-use types, differed significantly 
between populations (P = 9.1e–8); Estonian subjects lived in more rural surroundings than the Finnish 
subjects. This is reflected in the analysis of dissimilarities, such that for both skin and nasal microbiota, 
land-use did not remain significant after correcting for the significant effect of population (P = .001). As 
reported before,19 land use was not associated with sensitisation in this data. Also, (taking a random 
sample of subjects from each population: nskin = 50, nnasal = 70), only 18% of variation along the land-use 
gradient could be predicted with skin microbiota (using 150 trees and 225 features) and 11% based on 
nasal microbiota (using 150 trees and 500 features), using random forest regression. Interestingly, while 
land-use was not associated with microbiota as a whole, there was a significant association between 
Acinetobacter composition in the nasal samples and land-use. After accounting for the population effect 
(P = .001), both the amount of agricultural land (P = .002) and forest cover (P = .029) were associated with 
similarity in Acinetobacter composition between samples (Bray&Curtis dissimilarity on sqrt transformed 
OTU-level counts).
3.4 Stool microbiota & other lifestyle factors
To account for possible dietary effects, we considered the influence of breastfeeding patterns on stool 
microbiota. While the duration of breastfeeding did not differ between populations (Table S3), those 
children that were exclusively breastfed for at least the first month of life were less likely to be sensitised 
at the age of 18 month (P = .00015), after accounting for population, mode of delivery, and the month to 
start on solid foods (Table 1). This could not be explained by between-population differences in exclusive 
breastfeeding (P = .59), indicating that this protective effect occurs across populations. Interestingly, stool 
microbial diversity was significantly reduced by breastfeeding at the time of sampling (P <.0001), again 
accounting for population, mode of delivery, and the month to start on solid foods (Table 1). Moreover, 
breastfeeding at time of sampling was also significantly associated with variation in between-sample 
(weighted) UniFrac distances (P = .002; Table 1), indicating that breastfeeding influenced the composition 
of the gut microbial community. Particularly, breastfeeding was associated with an increase in the 
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Finally, we tested whether the amount of animal contact in early life (6 months) was 
associated with later sensitisation and microbial composition (measured at 18 months). While animal 
contact was significantly more intensive in Estonia as compared to Finland (P = 1.44e–7), it was not 
associated with allergic sensitisation (P = .94), after accounting for the between-population difference 
(P = .041). However, stool microbiota was significantly associated with animal contact (MRM on weighted 
UniFrac, R2 = .02, P = .003; corrected for between-population differences), which might be reflected in 
later health. When comparing individuals with low (1st quartile) and high (4th quartile) animal contact, a 
few OTUs identified by RFC, were significantly associated with animal contact. These OTUs represented 
the genera of Anaerostipes (Kruskal-Wallis test, P = 0.0023), Blautia (P = 0.0074), and Bacteroidetes (P = 
0.014), all more abundant in the high-contact group.
4. Discussion
In this study of 6-month-old Finnish and Estonian infants, our objective was to compare patterns in 
microbiota between populations and discover potential microbial predictors of early sensitisation to 
allergens. Indeed, Finnish and Estonian infants were found to differ in their skin, nasal, and stool 
microbiota. The role of these differences for later developing allergic sensitisation could not be confirmed 
at this stage. However, the results clearly indicate—in agreement with earlier findings—that observed 
between-population differences in epidemiology could be partly explained by differential exposure to 
environmental microbiota. Such a conclusion is supported by the fact that the Estonian cohort is exposed 
to more rural environment and they also tend be in closer contact with farm animals as compared to the 
Finnish cohort.
The contrasting microbial community composition between Finnish and Estonian children 
on the skin and the nasal epithelium was best characterised by differential abundance of several OTUs 
from the genus Acinetobacter (Fig. 2a,b). In particular, we found that A. lwoffii (and the Genus in general) 
was substantially more abundant, and genetically more diverse, in the skin and nasal samples from 
Estonian than Finnish infants (Fig. 3). This resonates with our earlier observation that adolescents in the 
Russian Karelia have significantly higher abundance of more diverse A. lwoffii on their skin and nasal 
epithelium than their Finnish counterparts.8 Importantly, the present results indicate that these 
differences are detectable already during infancy and precede the development of allergic sensitisation. 
This suggests sustained exposure to Acinetobacter in these populations, which is likely to begin already 
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Within the genus Acinetobacter, A. lwoffii seems to be the most common commensal on 
human skin and nasal mucosa.22,23 These bacteria are found in soil,24 but they are also relatively abundant 
in cowshed microflora.7 This indicates that the living environment and lifestyle might contribute to the 
colonisation of this bacterium to the body, which could explain the observed between-population 
differences. This is in turn supported by the previous observation that exposure to A. lwoffii in the living 
environment is associated with reduced risk of allergic sensitisation(25). In the present context, it would 
be extremely interesting to follow health outcomes of the participants in later life to see whether this is 
indeed the case.
Remarkably, A. lwoffii has been shown to polarize the immune system towards Th1 
responses in a mouse model.7,26 Furthermore, even prenatal exposure to A. lwoffii can significantly 
prevent the development of an asthmatic phenotype in the progeny in the mouse model.27,28 For 
example, Brand et al.28 showed that the exposure of the mother to A. lwoffii leads to epigenetic 
modifications in the progeny, promoting the production of IFN-. More recently, Fyhrquist et al.26 
demonstrated that exposure to A. lwoffii through the skin is associated with elevated expression of IL-10 
and IFN-, and suppression of IL-5 and IL-13 expression. This local Th1-polarisation of the immune 
response was also associated with systemic protection from allergic sensitisation and inflammation on 
allergen challenge. These experimental findings, together with our observations, suggest that the 
Estonian and Russian children are being protected against allergic sensitisation via both pre- and 
postnatal exposure to Acinetobacter.
Also, the faecal samples at the age of 6 months differed between populations, but the 
differences were less clear. While the relatively small between-population difference is understandable 
due to the selectivity of the gut habitat,17,29 Estonian children had a more diverse gut microbiota 
compared to Finnish children. Lower diversity of gut microbiota has been associated with development of 
allergic diseases,30 which is in line with our findings of reduced diversity in a population sampled from a 
country with higher prevalence of allergic diseases. However, it is not clear why this difference arises. In 
both cohorts, breastfeeding was found to be protective against sensitisation. Breastfeeding was also 
associated with an increase in the abundance of Lactobacillaceae, in agreement with previous reports.31 
This could relate to the protective role of breastfeeding via increased colonic production of short-chained 
fatty acids,32 which can shape the immunological environment in the lung and influence the severity of 
allergic inflammation.33 Notably, the compositional change in gut microbiota in the context of 
breastfeeding was also associated with reduced microbial diversity. We interpret this as the functional 
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We searched for predictors of early allergic sensitisation at the age of 18 months and found 
the detected differences in microbiotas to be somewhat surprising. Microbial diversity tended to be 
higher in sensitised children as compared to healthy children (Fig. 1), although these differences were not 
statistically significant. Additionally, A. lwoffii tended to be more abundant in sensitised compared to 
healthy infants (Fig. 3). Based on the assumption that higher microbial diversity is associated with 
protection from allergic diseases, and the fact that A. lwoffii being more abundant in Estonian samples 
was proposed to play a role in a lower allergy prevalence in this population, one might have expected to 
see an opposite pattern. It should be kept in mind that it is not clear that higher microbial diversity in the 
gut per se would be beneficial.17 Patterns in diversity likely arise from interactions between taxa, which 
are affected by factors such as diet and medication.17 
Another possible explanation could be that our selected endpoint, sensitisation at 18 
months of age, was not detecting true atopic development in our study population but rather reflected 
exposure of these infants to different allergens. Consequently, a child displaying an IgE response to 
allergens could merely have been exposed to a larger array or higher loads of these allergens, which 
might also be evident as a more diverse microbiota. According to Lynch et al.,34 such a scenario can 
actually protect against, rather than predispose to, allergic disease. It is possible that at the age of 18 
months, the children sensitised do not necessarily represent children who will later develop allergic 
diseases but rather this IgE response will later dissolve. For example, in early life, sensitisation towards 
food allergens is more frequent (here the maximum IgE at 18 months came from a food allergen in 78% of 
the subjects) than in later life, and for example in a German study, two-thirds of the children with 
sensitisation by the first year of life did not develop any atopic disease by the age of six years.35
Also, sensitisation to dust mite—especially monosensitisation—might not be related to 
later atopic diseases but could even provide protection from such conditions.36 Only three children, 
however, one Estonian and two Finnish, were sensitised to dust mite at the level of 0.35 kU/L. None of 
these children were monosensitised, although dust mite IgE levels higher than 0.1. kU/L were more 
common among Estonian than Finnish children. However, breastfeeding was a significant factor 
potentially contributing to the development of sensitisation; infants exclusively breastfed for at least one 
month were less likely to be sensitised at the age of 18 months. While this corroborates many earlier 
studies describing breastfeeding as a protective factor for allergic diseases,37 there are also several studies 
that do not agree.38,39
A limitation of our study is that the included children represent selected cases in terms of 
HLA class II genetics. Accordingly, the results might not directly be generalizable to the whole population 
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samples at the age of 6 months, which in the light of recent findings might already be late. Especially the 
alterations in stool microbiota have often been described very early in infancy: Arrieta et al.18 reported a 
transient intestinal microbial dysbiosis at 3 months of age in infants at high risk of later asthma 
development, which had mostly disappeared already at 1 year of age. Even earlier differences in 
association with later development of allergic disease have been reported,30,40 and in the DIABIMMUNE 
cohort also differences in umbilical cord blood transcriptomics have been described.41
Another limitation is that the number of subjects is small. This practically prevents any 
thorough adjustment of results with various demographic factors,42 such as breastfeeding, age at solid 
food introduction, number of siblings, day care attendance, exposure to smoking and pets, living on a 
farm, land-use, and mode of delivery (Table S3). Especially factors associated with the living environment 
and lifestyle are very likely to affect individual skin/nasal microbiota.43,44 While we cannot establish 
causalities in this study, we feel that previous experimental work7,26,27 provides a solid mechanistic 
foundation that supports our results. 
To conclude, in this nested case-control study from DIABIMMUNE infants with signs of 
allergic sensitisation at the age of 18 months, we described differing nasal and skin microbiota between 
Finland and Estonia. Namely, Acinetobacter lwoffii was more abundant and diverse in Estonian infants 
already at the age of 6 months, which could provide one potential explanation for the allergy gap 
between these populations. Differences in gut microbiota or between children later developing allergen-
specific IgE responses were less clear. Possibly, studies from different time points of sample collection or a 
longer follow-up to detect development of the allergic phenotype could provide a more conclusive 
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Table 1. (a) Exclusive breastfeeding at 1 month of age reduced the risk (OR) of allergic sensitisation 
(logistic regression model). (b) Breastfeeding at the time of sampling reduced microbial (Shannon) 
diversity (generalised least squares model, account for between-group residual variation) and community 
composition (weighted UniFrac distance, permutational regression on distance matrices) in stool samples. 
All analyses were controlled for country, delivery mode (vaginal or caesarean section = CS), number of 
siblings, and the month when solid foods were included in the diet. 
Response Predictor OR/Estimate/R2 P
(a) Sensitisation Country (Estonia) 0.47 0.018
Delivery mode (CS) 0.47 0.12
Number of siblings 0.67 0.009
Month to start solid food 1.13 0.45
Exclusive breastfeeding at 1 mon 0.29 0.0003
(b) Diversity Country (Estonia) 0.40 <.0001
Delivery mode (CS) –0.10 0.70
Number of siblings –0.01 0.30
Month to start solid food –0.06 0.0001
Breastfeeding at 6 mon –0.30 <.0001
(c) Composition Country 0.02 0.003
Delivery mode 0.02 0.002
Number of siblings 0.01 0.14
Month to start solid food 0.02 0.003
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Legends for the figures
Figure 1  Microbial diversity (Shannon’s index) in different sample types (skin, nasal, and stool), 
comparing healthy and sensitised subjects among the Finnish and Estonian cohorts. 
Figure 2  Ordination of community composition and the top discriminative OTUs for each cohort 
in either the (a) skin, (b) nasal, or (c) stool samples. Most important OTUs differing between 
Finnish and Estonian children were found with random forest classification. Ordinations were 
based on the Bray&Curtis dissimilarity.
Figure 3  (a) Proportional abundance (b) and the oligotype profile of OTU-108 (Acinetobacter 
lwoffii) in healthy and sensitised Finnish and Estonian children, in both skin and nasal samples. 
An oligotype is a group of reads that are binned together based on the nucleotides they possess 
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